Somnambulism is a non-rapid eye movement sleep parasomnia with potential for significant injury as well as functional nighttime and daytime impairment. Clonazepam is frequently used as first line pharmacotherapy. However, the optimal treatment of somnambulism has not been established. In this article, we present the cases of two patients with severe somnambulism who showed a significant therapeutic response to osmotic release oral system methylphenidate (OROS-MPH). In addition to its practical therapeutic implications, this first report of the successful treatment of somnambulism with OROS-MPH may provide additional insight into the neurobiological underpinnings of this medical condition.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6853387 | PMC |
| http://dx.doi.org/10.5664/jcsm.8040 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Evaluation of pitolisant, sodium oxybate, solriamfetol, and modafinil for the management of narcolepsy: a retrospective analysis of the FAERS database.
Front Pharmacol
November 2024
Department of Pharmacology, University of the Basque Country UPV/EHU, Leioa, Spain.
Article Synopsis
- The study investigates the safety of various medications for narcolepsy, a lifelong neurological disorder, using five years of data from the FDA Adverse Event Reporting System (FAERS) to analyze pharmacological treatments like pitolisant, sodium oxybate, solriamfetol, and modafinil.
- Data analysis revealed significant signals for adverse drug events (ADEs), especially psychiatric and nervous system-related issues, with sodium oxybate raising concerns about suicidal thoughts and respiratory problems, while other medications highlighted issues like drug inefficacy and pregnancy-related risks.
- Overall, findings suggest that adverse reactions align with existing product warnings, emphasizing the need for careful management and monitoring of narcolepsy treatments.
Associations between self-reported parasomnias and psychiatric illness in 370,000 patients with sleep disorders.
Psychiatry Clin Neurosci
November 2024
Stanford University Center for Sleep and Circadian Sciences, Stanford University, Palo Alto, California, USA.
Article Synopsis
- The study aimed to analyze self-reported parasomnias in patients with sleep disorders and examine their connections to psychiatric illnesses and sleep assessments.
- Data were gathered from 540,000 patients across various U.S. sleep centers, with a focus on those who reported experiencing parasomnias often or always.
- Results revealed a high correlation between frequent parasomnias and symptoms of depression, with specific sleep disturbances linked to medication effects and demographics, indicating a need for further exploration of these relationships.
Hypnosis in psychotherapy, psychosomatics and medicine. A brief overview.
Front Psychol
March 2024
MEG-Foundation, Wilhelmsthal-Hesselbach, Germany.
Article Synopsis
- Hypnosis has a rich 250-year history, evolving from early ideas like animal magnetism to play a role in psychotherapy, psychosomatics, and medicine, emphasizing imagination's importance in treatment.
- Concepts of the mind-body problem were explored in early romantic ideas of hypnosis, influencing modern understandings of unconscious processes and linking hypnosis to cognitive behavioral therapy techniques.
- Ongoing debates in social psychology question whether hypnosis is a unique state of consciousness or a normal interaction, with research showing that even moderately hypnotizable individuals can benefit and that factors like motivation and rapport are crucial for effective hypnotherapy.
Somnambulism.
Sleep Med Clin
March 2024
Department of Neurology, Sleep-Wake Disorders Unit, Gui-de-Chauliac Hospital, CHU Montpellier, INSERM Institute of Neurosciences of Montpellier, University of Montpellier, France. Electronic address:
Article Synopsis
- * It exists on a spectrum that includes other conditions like confusional arousal and night terrors, and while often seen as harmless, it can have serious social, personal, and legal implications.
- * This review highlights the current understanding of somnambulism, focusing on its clinical features, diagnostic methods, and the impact it can have on individuals' lives.
Sleep-Related Dissociative Disorders.
Sleep Med Clin
March 2024
Department of Psychiatry, University of Michigan Sleep Disorders Center, University of Michigan, C728 Med Inn Building, SPC 5845, 1500 East Medical Center Drive, Ann Arbor, MI 48109, USA. Electronic address:
Article Synopsis
- Sleep-related dissociative disorders occur during sleep or while transitioning between sleep and wakefulness, displaying a variety of behaviors that can pose risks of injury.* -
- These episodes often occur alongside daytime dissociative experiences and are frequently linked to trauma and other mental health issues.* -
- Diagnosis involves clinical history and polysomnography, while treatment options are limited; however, some psychological interventions have shown effectiveness in a few cases.*
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!